Wealth Enhancement Trust Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139K Buy
2,412
+1,124
+87% +$64.5K 0.02% 324
2026
Q1
$78.1K Sell
1,288
-232
-15% -$13.5K 0.01% 388
2025
Q4
$82K Buy
+1,520
New +$73.1K 0.01% 363

Other funds holding BMY

Wealth Enhancement Trust Services's BMY Position: Q2 2026 in Review

Wealth Enhancement Trust Services increased its Bristol-Myers Squibb (BMY) stake by 87% in Q2 2026, buying an estimated $64.5K and bringing the position to 2,412 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #324.

Wealth Enhancement Trust Services first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,009 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wealth Enhancement Trust Services held 2,412 shares of Bristol-Myers Squibb worth $139K as of Q2 2026.
  • Wealth Enhancement Trust Services bought 1,124 Bristol-Myers Squibb shares in Q2 2026, an estimated $64.5K.
  • Bristol-Myers Squibb made up 0.02% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #324 holding.
  • Wealth Enhancement Trust Services first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • 2,009 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.